Community-Acquired burkholderia cepacia complex (BCC) pneumonia in a lung cancer patient on erlotinib
Community-acquired Burkholderia cepacia pneumonia is uncommon. We report a 32-year-old female who was on oral erlotinib, a tyrosine kinase inhibitor, for 2 years for her lung cancer and developed community-acquired Burkholderia cepacia pneumonia, which was confirmed by blood culture. The patient imp...
Sábháilte in:
| Príomhchruthaitheoirí: | , , , |
|---|---|
| Formáid: | Artigo |
| Teanga: | Inglês |
| Foilsithe / Cruthaithe: |
Wolters Kluwer Medknow Publications
2023-01-01
|
| Sraith: | Lung India |
| Ábhair: | |
| Rochtain ar líne: | http://www.lungindia.com/article.asp?issn=0970-2113;year=2023;volume=40;issue=4;spage=364;epage=365;aulast=Mohapatra |
| Clibeanna: |
Níl clibeanna ann, Bí ar an gcéad duine le clib a chur leis an taifead seo!
|